The Chemotherapy Cornerstone: How the Doxorubicin Market Is Evolving in a Changing Oncology Landscape
For decades, doxorubicin has been a cornerstone of chemotherapy, a powerful anthracycline antibiotic used to treat a wide range of cancers, including breast cancer, leukemia, and lymphomas. Despite the rise of targeted therapies, doxorubicin remains an essential and effective agent, and its market continues to show steady growth. The Doxorubicin Market, valued at USD 2.4 Billion in 2024, is on...
0 Comments 0 Shares 115 Views 0 Reviews